Altered mitogen-activated protein kinase signaling in dystrophic (mdx) muscle

Muscle Nerve. 2012 Sep;46(3):374-83. doi: 10.1002/mus.23312.

Abstract

Introduction: Duchenne muscular dystrophy (DMD) results from a deficiency in the protein, dystrophin. Dystrophic myotubes are susceptible to stressful stimuli. This may be partly due to altered regulation of pro-survival signaling pathways, but a role for mitogen-activated protein (MAP) kinases has not been investigated.

Methods: We examined patterns of phosphorylation of key MAP kinase proteins in cultured myotubes responding to oxidative stress, and in muscle tissue in vivo.

Results: Dystrophic (mdx) myotubes have an increased susceptibility to oxidant-induced death compared with wild-type (C57Bl/10ScSn) myotubes. This correlates with late phosphorylation of c-Jun N-terminal kinase (JNK), and persistently high p38 MAP kinase phosphorylation in mdx myotubes. JNK and extracellular signal-regulated kinase 1/2 (ERK1/2) also showed altered phosphorylation levels in mdx muscle tissue.

Conclusions: We show altered patterns of MAP kinase protein phosphorylation in dystrophic muscle in vitro and in vivo. These pathways may be novel pharmacological targets for treating DMD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dystrophin / genetics
  • Dystrophin / metabolism
  • MAP Kinase Signaling System / genetics
  • MAP Kinase Signaling System / physiology*
  • Mice
  • Mice, Inbred mdx
  • Mitogen-Activated Protein Kinases / metabolism*
  • Muscle, Skeletal / metabolism*
  • Muscular Dystrophy, Animal / genetics
  • Muscular Dystrophy, Animal / metabolism*
  • Phosphorylation

Substances

  • Dystrophin
  • Mitogen-Activated Protein Kinases